SCHEMBL553542

SCHEMBL553542

CC(C)(C)OP(=O)([O-])OC(C)(C)C.CC(C)(C)OP(=O)([O-])OC(C)(C)C.[Ba+2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Silver SCHEMBL555009 0.94
SCHEMBL7860312 0.94
SCHEMBL920065 0.94
Potassium Ion SCHEMBL553768 0.94 SLC34A1 (0.32)
Lithium Ion SCHEMBL21749348 0.94
SCHEMBL4823616 0.94
Water SCHEMBL28672424 0.91 SLC34A1 (0.30)
Tetramethylammonium Ion SCHEMBL1758243 0.88
Lithium Ion SCHEMBL21749343 0.75
Potassium Ion SCHEMBL18394942 0.75 SLC34A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160176906-A1 Chemical Compounds ASTRAZENECA AB (SE) 2016-06-23 US disclosed
US-9248140-B2 Chemical compounds ASTRAZENECA AB (SE) 2016-02-02 US disclosed
US-20150328239-A1 Chemical Compounds ASTRAZENECA AB (SE) 2015-11-19 US disclosed
US-9018381-B2 Chemical compounds ASTRAZENECA AB (SE) 2015-04-28 US disclosed
US-20130310344-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ASTRAZENECA AB (UK) 2013-11-21 US disclosed
EP-2601177-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS AstraZeneca AB (SE) 2013-06-12 EP disclosed
US-20130040914-A1 PRODRUGS OF AN HIV REVERSE TRANSCRIPTASE INHIBITOR MERCK SHARP & DOHME CORP. 2013-02-14 US disclosed
US-20120035134-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2012-02-09 US disclosed
WO-2012017251-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ASTRAZENECA AB (SE) 2012-02-09 WO disclosed